Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' ARMSTRONG PW' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 217 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. McAlister, FA; Lawson, FME; Teo, KK; Armstrong, PW
      Randomised trials of secondary prevention programmes in coronary heart disease: systematic review

      BRITISH MEDICAL JOURNAL
    2. Armstrong, PW
      New advances in the management of acute coronary syndromes: 2. Fibrinolytic therapy for acute ST-segment elevation myocardial infarction

      CANADIAN MEDICAL ASSOCIATION JOURNAL
    3. Armstrong, PW
      New advances in the management of acute coronary syndromes

      CANADIAN MEDICAL ASSOCIATION JOURNAL
    4. Kaul, P; Fu, YL; Chang, WC; Harrington, RA; Wagner, GS; Goodman, SG; Granger, CB; Moliterno, DJ; Van de Werf, F; Califf, RN; Topol, EJ; Armstrong, PW
      Prognostic value of ST segment depression in acute coronary syndromes: Insights from PARAGON-A applied to GUSTO-IIb

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    5. Bahit, MC; Topol, EJ; Califf, RM; Armstrong, PW; Criger, DA; Hasselbad, V; Betriu, A; Hirsh, J; Ardissino, D; Granger, CB
      Reactivation of ischemic events in acute coronary syndromes: Results from GUSTO-IIb. (vol 37, pg 1001, 2001)

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    6. Bahit, MC; Topol, EJ; Califf, RM; Armstrong, PW; Criger, DA; Hasselblad, V; Betriu, A; Hirsh, J; Ardissino, D; Granger, CB
      Reactivation of ischemic events in acute coronary syndromes: Results from GUSTO-IIb

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    7. Naik, GOA; Moe, GW; Armstrong, PW
      Specific and non-specific measurements of tissue angiotensin II cascade members

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    8. White, HD; Simes, RJ; Aylward, PEG; Armstrong, PW; Califf, RM; French, JK; Granger, CB; Marschner, IC; Topol, EJ; Van de Werf, FJ; Wilcox, RG
      Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial

      LANCET
    9. Van de Werf, F; Armstrong, PW; Granger, C; Wallentin, L
      Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction

      LANCET
    10. Topol, EJ; Califf, RM; Van de Werf, F; Willerson, JT; Booth, J; White, H; Clayman, M; Deckelbaum, L; Lincoff, AM; Ohman, EM; Bates, E; Gibler, WB; Hochman, J; Kleiman, N; Grinfeld, L; Aylward, P; Armstrong, PW; Heikkila, J; Vahanian, A; Steg, G; Bode, C; Adgy, AAJ; Guetta, V; Ardissino, D; Savonitto, S; Bar, F; Simoons, M; Kontny, F; White, H; Sadowski, Z; Seabra-Gomes, R; Dalby, A; Betriu, A; Swahn, E; Wilcox, R; Frye, RL; Bertrand, ME; DeMets, D; Fox, KKA; Fuster, V; Lee, KL; McCarthy, C; Waller, M; Scherer, J; van de Kerkhove, A; Kukulewicz, L; Booth, JE; Del Valle, M; Hibert, D; Brannon, D
      Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO randomised trial

      LANCET
    11. Aronow, HD; Topol, EJ; Roe, MT; Houghtaling, PL; Wolski, KE; Lincoff, AM; Harrington, RA; Califf, RM; Ohman, EM; Kleiman, NS; Keltai, M; Wilcox, RG; Vahanian, A; Armstrong, PW; Lauer, MS
      Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study

      LANCET
    12. Alpert, JS; Thygesen, K; Antman, E; Bassand, JP; Apple, F; Armstrong, PW; Bassand, JP; de Luna, AB; Beller, G; Breithardt, G; Chaitman, BR; Clemmensen, P; Falk, E; Fishbein, MC; Galvani, M; Garson, A; Grines, C; Hamm, C; Hoppe, U; Jaffe, A; Katus, H; Kjekshus, J; Klein, W; Klootwijk, P; Lenfant, C; Levy, D; Levy, RI; Luepker, R; Marcus, F; Naslund, U; Ohman, M; Pahlm, O; Poole-Wilson, P; Popp, R; Pyorala, J; Ravkilde, J; Rehnquist, N; Roberts, W; Roberts, R; Roelandt, J; Ryden, L; Sans, S; Simoons, ML; Thygesen, K; Tunstall-Pedoe, H; Underwood, R; Uretsky, BF; Van de Werf, F; Voipio-Pulkki, LM; Wagner, G; Wallentin, L; Wijns, W; Wood, D; Sendon, JLL; Tendera, M
      Myocardial infarction redefined - A consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction (Reprinted from J Am Coll Cardiol, vol36, pg 959-69, 2000)

      CLINICAL CHEMISTRY
    13. Fu, YL; Goodman, S; Chang, WC; Van de Werf, F; Granger, CB; Armstrong, PW
      Time to treatment influences the impact of ST-segment resolution on one-year prognosis - Insights from the Assessment of the Safety and Efficacy of aNew Thrombolytic (ASSENT-2) trial

      CIRCULATION
    14. Hudson, MP; Granger, CB; Topol, EJ; Pieper, KS; Armstrong, PW; Barbash, GI; Guerci, AD; Vahanian, A; Califf, RM; Ohman, EM
      Early reinfarction after fibrinolysis - Experience from the Global Utilization of Streptokinase and Tissue plasminogen activator (Alteplase) for occluded coronary arteries (GUSTO I) and Global Use of Strategies to Open occluded coronary arteries (GUSTO III) trials

      CIRCULATION
    15. Armstrong, PW; Granger, C; Van de Werf, F
      Bolus fibrinolysis - Risk, benefit, and opportunities

      CIRCULATION
    16. Newby, LK; Ohman, EM; Christenson, RH; Moliterno, DJ; Harrington, RA; White, HD; Armstrong, PW; Van de Werf, F; Pfisterer, M; Hasselblad, V; Califf, RM; Topol, EJ
      Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin T-positive status - The PARAGON-B troponin T substudy

      CIRCULATION
    17. Armstrong, PW; Collen, D
      Fibrinolysis for acute myocardial infarction - Current status and new horizons for pharmacological reperfusion, part 2

      CIRCULATION
    18. Armstrong, PW; Collen, D
      Fibrinolysis for acute myocardial infarction - Current status and new horizons for pharmacological reperfusion, Part 1

      CIRCULATION
    19. Massie, BM; Armstrong, PW; Cleland, JGF; Horowitz, JD; Packer, M; Poole-Wilson, PA; Ryden, L
      Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure - Results from the ATLAS trial

      ARCHIVES OF INTERNAL MEDICINE
    20. McAlister, FA; Lawson, FME; Teo, KK; Armstrong, PW
      A systematic review of randomized trials of disease management programs inheart failure

      AMERICAN JOURNAL OF MEDICINE
    21. Angeja, BG; Alexander, JH; Chin, R; Li, X; Barron, HV; Armstrong, PW; Granger, CB; Van de Werf, F; Gibson, CM
      Safety of the weight-adjusted dosing regimen of tenecteplase in the ASSENT-trial

      AMERICAN JOURNAL OF CARDIOLOGY
    22. O'Shea, JC; Fu, YL; Chang, WC; Armstrong, PW
      A tale of two countries: Insights from the differences in Canadian/American patterns of care for patients with acute coronary syndromes

      AMERICAN HEART JOURNAL
    23. Sculpher, MJ; Poole, L; Cleland, J; Drummond, M; Armstrong, PW; Horowitz, JD; Massie, BM; Poole-Wilson, PA; Ryden, L
      Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) study

      EUROPEAN JOURNAL OF HEART FAILURE
    24. Sholter, DE; Armstrong, PW
      Adverse effects of corticosteroids on the cardiovascular system

      CANADIAN JOURNAL OF CARDIOLOGY
    25. Chang, WC; Fu, YL; Ohman, EM; Gupta, M; Morris, A; Roth, SN; Granger, CB; Califf, RM; Topol, EJ; Mark, DB; Armstrong, PW
      Temporal evolution in the management of acute ST elevation myocardial infarction: The seven-year GUSTO experience from Canada and the United States

      CANADIAN JOURNAL OF CARDIOLOGY
    26. Alpert, JS; Antman, E; Apple, F; Armstrong, PW; Bassand, JP; de Luna, AB; Beller, G; Breithardt, G; Chaitman, BR; Clemmensen, P; Falk, E; Fishbein, MC; Galvani, M; Garson, A; Grines, C; Hamm, C; Jaffe, A; Katus, H; Kjekshus, J; Klein, W; Klootwijk, P; Lenfant, C; Levy, D; Levy, RI; Luepker, R; Marcus, F; Naslund, U; Ohman, M; Pahlm, O; Poole-Wilson, P; Popp, R; Alto, P; Pyorala, K; Ravkilde, J; Rehnquist, N; Roberts, W; Roberts, R; Roelandt, J; Ryden, L; Sans, S; Simoons, ML; Thygesen, K; Tunstall-Pedoe, H; Underwood, R; Uretsky, BF; Van de Werf, F; Voipio-Pulkki, LM; Wagner, G; Wallentin, L; Wijns, W; Wood, D
      Myocardial infarction redefined - A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    27. Hasdai, D; Califf, RM; Thompson, TD; Hochman, JS; Ohman, EM; Pfisterer, M; Bates, ER; Vahanian, A; Armstrong, PW; Criger, DA; Topol, EJ; Holmes, DR
      Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    28. Armstrong, PW
      First steps in analysing NHS waiting times: avoiding the 'stationary and closed population' fallacy

      STATISTICS IN MEDICINE
    29. Armstrong, PW
      Reperfusion synergism: will it be both sustained and safe?

      EUROPEAN HEART JOURNAL
    30. Ryden, L; Armstrong, PW; Cleland, JFG; Horowitz, JD; Massie, BM; Packer, M; Poole-Wilson, PA
      Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus - Results from the ATLAS trial

      EUROPEAN HEART JOURNAL
    31. Alpert, JS; Antman, E; Apple, F; Armstrong, PW; Bassand, JP; de Luna, AB; Beller, G; Breithardt, G; Chaitman, BR; Clemmensen, P; Falk, E; Fishbein, MC; Galvani, M; Garson, A; Grines, C; Hamm, C; Hoppe, U; Jaffe, A; Katus, H; Kjekshus, J; Klein, W; Klootwijk, P; Lenfant, C; Levy, D; Levy, RI; Luepker, R; Marcus, F; Naslund, U; Ohman, M; Pahlm, O; Poole-Wilson, P; Popp, R; Pyorala, K; Ravkilde, J; Rehnquist, N; Roberts, W; Roberts, R; Roelandt, J; Ryden, L; Sans, S; Simoons, ML; Thygesen, K; Tunstall-Pedoe, H; Underwood, R; Uretsky, BF; de Werf, FV; Voipio-Pulkki, LM; Wagner, G; Wallentin, L; Wijns, W; Wood, D
      Myocardial infarction redefined - A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction

      EUROPEAN HEART JOURNAL
    32. Armstrong, PW; Granger, C; Van de Werf, F
      Intracranial haemorrhage with bolus thrombolytic agents

      LANCET
    33. Topol, CE; Califf, RM; Simes, RJ; Van de Werf, F; Diaz, R; Paolasso, E; Aylward, PE; Keech, A; Klein, W; Piegas, L; Tomov, I; Armstrong, PW; Widimsky, P; Grande, P; Halinen, M; Vahanian, A; Neuhaus, K; Dimas, AP; Preda, I; Kristinsson, A; Tzivoni, D; Ardissino, D; White, HD; Madsen, S; Sugrue, D; Sadowski, Z; Seabra-Gomes, R; Apetrei, E; Dalby, A; Betriu, A; Pfisterer, M; Verheugt, F; Fox, K; Bates, ER; Gibler, WB; Granger, CB; Harrington, RA; Hochman, JS; Holmes, DR; Kleiman, NS; Lee, KL; Moliterno, DJ; Newby, LK; Ohman, EM; Califf, R; Newby, K; Zillman, L; Lee, K; Lemons, P; McCourt, B; Campbell, C; Tardiff, B; Snapp, J; Bassett, K; Hodgson, P; Hannan, K; Kandzari, L; Hawkins, S; Hinman-Smith, E; McDougal, M; Raffetto, K; Thompson, D; Wehrle, T; Ange, C; Brown, R; Grissom, G; Heuckel, M; McCall, J; Pennachi, W; Spychala, M; Veasey, S; Pullium, M; Journey, T; Quintero, K; Mark, D; Davidson-Ray, L; Diner, L; Nelson, C; Sowers, C; Webb, G; Young, M; Bhapkar, M; Pacchiana, C; Sparapani, R; Tuttle, R; Weaver, D; Borzak, S; Douthat, L; Topol, E; Moliterno, D; Konczos, L; Baishnab, R; Baishnab, R; Bakos, A; Blashford, L; Bratsch, J; Brown, K; Cadorini, E; Carlson, J; Clemmons, P; DelValle, M; Drabik, M; Fu, G; Gates, K; Gibson, Y; Heil, L; Hill, N; Klancar, R; McHale, B; Montague, E; Pasca, N; Pergi, L; Randall, R; Rosso, R; Sankovich, K; Smith, D; Wisniewski, L; Witkowski, M; Zovkic, V; Alexander, K; Bhatt, D; Brener, S; Campbell, L; Cho, L; Cole, C; Deedy, M; Foody, J; Gassler, J; Ghaffari, S; Haas, G; Kapadia, S; Lauer, M; Lauer, MS; Lincoff, M; Lutton, S; Marso, S; Mukherjee, D; Patel, V; Penn, M; Robbins, M; Roe, M; Sila, C; Thamilarasan, M; Wagner, G; Armstrong, P; Bestilny, S; Van de Werf, F; Budts, W; Graux, S; Luyten, A; Simes, J; Keech, A; Kava, M; Bower, T; Chan, S; Crampton, L; Monro, C; Nayak, M; Parente, G; Riley, V; Wilton, D; Aylward, P; Dolan, S; Thomas, C; White, H; Scott, M; Frye, R; Alpert, J; Bertrand, M; Ryan, T; Fisher, L; Asarch, L; Smith, M; Lim, L; Bokslag, M; Chiu, P; Chung, J; Collins, S; Dougherty, C; Guimaraes, D; Hakim, Z; Mathieson, J; Montgomery, L; Novotny, B; Steiner, B; Wittke, B
      Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial

      LANCET
    34. Newby, LK; Eisenstein, EL; Califf, RM; Thompson, TD; Nelson, CL; Peterson, ED; Armstrong, PW; Van de Werf, F; White, HD; Topol, EJ; Mark, DB
      Cost effectiveness of early discharge after uncomplicated acute myocardialinfarction.

      NEW ENGLAND JOURNAL OF MEDICINE
    35. Harrington, RA; Armstrong, PW; Graffagnino, C; Van de Werf, F; Kereiakes, DJ; Sigmon, KN; Card, T; Joseph, DM; Samuels, R; Granett, J; Chan, R; Califf, RM; Topol, EJ
      Dose-finding, safety, and tolerability study of an oral platelet glycoprotein IIb/IIIa inhibitor, lotrafiban, in patients with coronary or cerebral atherosclerotic disease

      CIRCULATION
    36. Uretsky, BF; Thygesen, K; Armstrong, PW; Cleland, JG; Horowitz, JD; Massie, BM; Packer, M; Poole-Wilson, PA; Ryden, L
      Acute coronary findings at autopsy in heart failure patients with sudden death - Results from the Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial

      CIRCULATION
    37. Willerson, JT; Armstrong, PW
      Introduction to 50th Anniversary Celebration Issue for Circulation

      CIRCULATION
    38. Theroux, P; Willerson, JT; Armstrong, PW
      Progress in the treatment of acute coronary syndromes a 50-year perspective (1950-2000)

      CIRCULATION
    39. Topol, EJ; Ohman, EM; Armstrong, PW; Wilcox, R; Skene, AM; Aylward, P; Simes, J; Dalby, A; Betriu, A; Bode, C; White, HD; Hochman, JS; Emanuelson, H; Vahanian, A; Sapp, S; Stebbins, A; Moliterno, DJ; Califf, RM
      Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction - Results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) IIItrial

      CIRCULATION
    40. Fu, YL; Chang, WC; Mark, D; Califf, RM; Mackenzie, B; Granger, CB; Topol, EJ; Hlatky, M; Armstrong, PW
      Canadian-American differences in the management of acute coronary syndromes in the GUSTO IIb trial - One-year follow-up of patients without ST-segment elevation

      CIRCULATION
    41. Cirillo, W; Decanini, R; Coelho, OR; Avezum, A; Peixoto, MSP; Piegas, LS; Neto, JMR; Paiva, M; Carvalho, AC; de Almeida, DR; Fernandes, IML; Malavasi, MC; Pavanello, R; Canesin, M; Ishii, S; Barretto, ACP; Imrie, J; Moore, R; Woo, K; Bernstein, V; Mizgala, HF; Mooney, S; Hilbich, D; Kuritzky, R; Rupka, DW; Blackwell, MM; Breakwell, L; Kornder, JM; Pearce, SA; Polasek, P; Richardson, PM; Grant, J; Isaac, D; Beresford, P; Giannoccaro, P; Roth, D; Greenwood, P; Muzyka, T; Prosser, A; Brass, N; Hui, W; Kvill, L; Goeres, M; MacDonald, K; Senaratne, M; Hill, L; Humen, D; Teo, KK; Habib, N; Habib, N; Teekasingh, S; MacKenzie, J; McEwen, B; Morris, A; Dhair, A; Lai, C; Kwiatkowski, K; Brugos, J; Nawaz, S; Andrews, J; Moe, G; Freskiw, K; Gilbert, B; Morgan, CD; Bozek, B; Halperin, F; Ricci, AJ; Singh, N; Cappelli, G; Boyne, T; Fallen, E; Panju, A; Woodcock, G; Kent, E; Kitching, AD; Sullivan, H; Tomson, D; McKelvie, RS; Tsuyuki, RT; Yusuf, S; Chan, YK; Thomson, D; Arnold, JMO; Hurwitz, G; Miles, R; Baker, A; Haspect, A; Smith, S; Bedard, J; Lavoie, L; Dufort, L; Harvey, R; Lepage, S; Elstein, E; Fitchett, D; Serpa, A; Day, L; Racine, N; Savard, D; Sestier, F; Gosselin, G; Rouleau, JL; White, M; Whittom, L; Kiwan, G; Kouz, SM; Laforest, M; Ouimet, H; Carmichael, P; Lenis, J; Auger, P; Grondin, F; Saulnier, D; Campeau, J; Dupuis, R; Lauzon, C; Genest, M; Robitaille, NM; Beaudoin, J; Belanger, N; Houde, G; Talbot, P; Cossett, J; Koilpillai, C; Sheridan, WJ; Tobin, M; Sussex, B; Ascoli, G; Fraticelli, A; Paciaroni, E; Como, CO; Belluschi, R; Ruffa, F; Tettamanti, F; Cobelli, F; Salvucci, F; Arpesella, R; Campana, C; Gavazzi, A; Cirrincione, V; Ingrilli, F; Sciortino, E; Boccanelli, A; Cacciatore, G; Menichelli, M; Bosimini, E; Giannuzzi, P; Marcassa, C; Porcu, M; Salis, S; Sanna, A; Comerio, G; Gronda, E; Mangiavacchi, M; Moccetti, T; Pasotti, E; Sessa, F; Levy, WC; Probstfield, J; Thompson, J; Gramberg, M; Grover, J; Towery, D; Ogunyankin, K; Singh, BN; Celano, J; Graham, S; Kohn, RM; Pande, P; Sass, A; Wiener, RS; Rydzinski, S; Starling, RC; Young, J; Hays, L; Naftilan, A; Miller, A; Varga, A; Wofford, R; Barnhill, S; Brito, RD; Harris, L; Haspect, A; Cristina, T; Jarosz, M; Kellen, J; Kingry, C; Letterer, R; La Forge, D; Liuni, C; MacKenzie, J; Magi, A; Stevens, K; Squires, P; Yusuf, S; Rouleau, JL; Maggioni, A; Arnold, JMO; Avezum, A; Burns, R; Floras, J; Gavazzi, A; Held, P; Hjalmarson, A; Isaac, D; Latini, R; Lindgren, E; McKelvie, RS; Piegas, LS; Pericak, D; Pogue, J; Probstfield, J; Smith, S; Swedberg, K; Teo, KK; Tsuyuki, RT; Vint-Reed, C; Wang, Y; White, M; Wiecek, EM; Young, J; Johnstone, D; Armstrong, PW; Packer, M; Wedel, H; Teo, KK; Gavazzi, A; Tsuyuki, RT; White, M; McKelvie, R; Anderson, M; Holadyk-Gris, I; Kucemba, K; MacKay, J; McKelvie, RS; Micks, M; Pericak, D; Pogue, J; Reeve, S; Robinson, L; Tsuyuki, RT; Tucker, J; Wiecek, EM; Wang, Y; Yusuf, S; Cernacek, P; Joyal, M; Poitras, N; Rouleau, JL; White, M; Sirois, P; Bevilacqua, M; Latini, R; Masson, S; Torri, M; Hall, C; Burns, RJ; Heeney, T; Tadros, S; White, M; Yusuf, S; McKelvie, RS; Pericak, D; Young, J; Latini, R; Pogue, J; Burns, RJ; Probstfield, J; Tsuyuki, RT; Maggioni, AP; Avezum, A; Rouleau, JL
      Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy - The randomized evaluation of strategies for left ventricular dysfunction pilot study

      CIRCULATION
    42. Boersma, E; Pieper, KS; Steyerberg, EW; Wilcox, RG; Chang, WC; Lee, KL; Akkerhuis, KM; Harrington, RA; Deckers, JW; Armstrong, PW; Lincoff, AM; Califf, RM; Topol, EJ; Simoons, ML
      Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation results from an international trial of 9461 patients

      CIRCULATION
    43. Califf, RM; Pieper, KS; Lee, KL; Van de Werf, F; Simes, RJ; Armstrong, PW; Topol, EJ
      Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries trial

      CIRCULATION
    44. Barbagelata, A; Califf, RM; Sgarbossa, EB; Goodman, SG; Knight, D; Mark, DB; Granger, CB; Agranatti, DA; Mautner, B; Ohman, EM; Suarez, LD; Armstrong, PW; Gates, K; Wagner, GS
      Use of resources, quality of life, and clinical outcomes in patients with and without new Q waves after thrombolytic therapy for acute myocardial infarction (from the GUSTO-I trial)

      AMERICAN JOURNAL OF CARDIOLOGY
    45. Armstrong, PW; Burton, JR; Palisaitis, D; Thompson, CR; Van de Werf, F; Rose, B; Collen, D; Teo, KK
      Collaborative Angiographic Patency Trial of Recombinant Staphylokinase (CAPTORS)

      AMERICAN HEART JOURNAL
    46. Armstrong, PW
      Improved outcome in heart failure

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    47. Armstrong, PW
      Unsticking platelets: the role of glycoprotein IIb/IIIa receptor blockade

      CANADIAN MEDICAL ASSOCIATION JOURNAL
    48. Batchelor, WB; Peterson, ED; Mark, DB; Knight, JD; Granger, CB; Armstrong, PW; Califf, RM
      A comparison of US and Canadian cardiac catheterization practices in detecting severe coronary artery disease after myocardial infarction: Efficiency, yield and long-term implications

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    49. Hasdai, D; Holmes, DR; Topol, EJ; Berger, PB; Criger, DA; Hochman, JS; Bates, ER; Vahanian, A; Armstrong, PW; Wilcox, R; Ohman, EM; Califf, RM
      Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase - Results fromGUSTO-III

      EUROPEAN HEART JOURNAL
    50. Wong, MP; Armstrong, PW
      Supraventricular tachycardia terminated by external mechanical stimulation: A case of "pothole conversion"

      PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    51. Van de Werf, F; Adgey, J; Ardissino, D; Armstrong, PW; Aylward, P; Barbash, G; Betriu, A; Binbrek, AS; Califf, R; Diaz, R; Fanebust, R; Fox, K; Granger, C; Heikkila, J; Husted, S; Jansky, P; Langer, A; Lupi, E; Maseri, A; Meyer, J; Mlczoch, J; Mocceti, D; Myburgh, D; Oto, A; Paolasso, E; Pehrsson, K; Seabra-Gomes, R; Soares-Piegas, L; Sugrue, D; Tendera, M; Topol, E; Toutouzas, P; Vahanian, A; Verheugt, F; Wallentin, L; White, H; Berioli, S; Bluhmki, E; Brower, R; Danays, T; Fox, NL; Girault, C; Goetz, G; Houbracken, K; Jakob, H; Kaye, J; Sarelin, H; Clow, FW; Hacke, W; von Kummer, L; Lesaffre, E; Bluhmki, E; Bogaerts, K; Munster, K; Scheys, I; Truyen, M; Clow, FW; Fox, KAA; Brower, R; Hallstrom, A; Jones, D; Maggioni, A; Weaver, D
      Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial

      LANCET
    52. Packer, M; Poole-Wilson, PA; Armstrong, PW; Cleland, JGF; Horowitz, JD; Massie, BM; Ryden, L; Thygesen, K; Uretsky, BF
      Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure

      CIRCULATION
    53. Armstrong, PW
      Pursuing progress in acute coronary syndromes

      CIRCULATION
    54. Ohman, EM; Armstrong, PW; White, HD; Granger, CB; Wilcox, RG; Weaver, WD; Gibler, WB; Stebbins, AL; Cianciolo, C; Califf, RM; Topol, EJ
      Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction

      AMERICAN JOURNAL OF CARDIOLOGY
    55. Alexander, JH; Harrington, RA; Tuttle, RH; Berdan, LG; Lincoff, AM; Deckers, JW; Simoons, ML; Guerci, A; Hochman, JS; Wilcox, RG; Kitt, MM; Eisenberg, PR; Califf, RM; Topol, EJ; Karsh, K; Ruzyllo, W; Stepinska, J; Widimsky, P; Boland, JB; Armstrong, PW
      Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes

      AMERICAN JOURNAL OF CARDIOLOGY
    56. McAlister, FA; Teo, KK; Taher, M; Montague, TJ; Humen, D; Cheung, L; Kiaii, M; Yim, R; Armstrong, PW
      Insights into the contemporary epidemiology and outpatient management of congestive heart failure

      AMERICAN HEART JOURNAL
    57. ARMSTRONG PW
      TOWARD IMPROVED CORONARY-ARTERY REVASCULARIZATION - IS THIS AS GOOD AS IT GETS

      CMAJ. Canadian Medical Association journal
    58. PFISTERER M; COX JL; GRANGER CB; BRENER SJ; NAYLOR CD; CALIFF RM; VANDEWERF F; STEBBINS AL; LEE KL; TOPOL EJ; ARMSTRONG PW
      ATENOLOL USE AND CLINICAL OUTCOMES AFTER THROMBOLYSIS FOR ACUTE MYOCARDIAL-INFARCTION - THE GUSTO-I EXPERIENCE

      Journal of the American College of Cardiology
    59. METZ BK; WHITE HD; GRANGER CB; SIMES RJ; ARMSTRONG PW; HIRSH J; FUSTER V; MACAULAY CM; CALIFF RM; TOPOL EJ
      RANDOMIZED COMPARISON OF DIRECT THROMBIN INHIBITION VERSUS HEPARIN INCONJUNCTION WITH FIBRINOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION- RESULTS FROM THE GUSTO-IIB TRIAL

      Journal of the American College of Cardiology
    60. LANGER A; KRUCOFF MW; KLOOTWIJK P; SIMOONS ML; GRANGER CB; BARR A; CALIFF RM; ARMSTRONG PW
      PROGNOSTIC-SIGNIFICANCE OF ST SEGMENT SHIFT EARLY AFTER RESOLUTION OFST ELEVATION IN PATIENTS WITH MYOCARDIAL-INFARCTION TREATED WITH THROMBOLYTIC THERAPY - THE GUSTO-I ST SEGMENT MONITORING SUBSTUDY

      Journal of the American College of Cardiology
    61. GRANGER CB; VANDEWERF F; ARMSTRONG PW; SIMES J; WHITE H; MACAULAY CM; CALIFF RM; TOPOL EJ
      HIRUDIN REDUCES DEATH AND MYOCARDIAL (RE)INFARCTION AT 6-MONTHS - FOLLOW-UP RESULTS OF THE GUSTO IIB TRIAL

      Journal of the American College of Cardiology
    62. ALEXANDER JH; HARRINGTON RA; GUERCI A; WEATHERLEY BD; KARSCH KR; CALIFF RM; TOPOL EJ; LINCOFF AM; ARMSTRONG PW
      PRIOR ASPIRIN USE POTENTIATES THE EFFECT OF GP IIB IIIA INHIBITION INPATIENTS WITH NON-ST ELEVATION ACUTE CORONARY SYNDROMES/

      Journal of the American College of Cardiology
    63. MOLITERNO DJ; HARRINGTON RA; NEWBY KL; ARMSTRONG PW; VANDEWERF F; WHITE HD; CALIFF RM; TOPOL EJ
      LATE DIVERGING EVENT CURVES FOR SURVIVAL FOLLOWING IIB IIIA ANTAGONISM IN PATIENTS WITH UNSTABLE ANGINA - PARAGON STUDY 1-YEAR FOLLOW-UP/

      Journal of the American College of Cardiology
    64. KRUCOFF MW; GREEN CL; TROLLINGER KM; GRANGER CB; OHMAN EM; OCONNOR CM; HARRINGTON RA; ARMSTRONG PW; SIMOONS ML; TOPOL EJ; CALIFF RM
      A COMPARISON OF STATIC SERIAL VS CONTINUOUS ST-SEGMENT RECOVERY TO PREDICT OUTCOME AFTER LYTICS FOR MI

      Journal of the American College of Cardiology
    65. DECKERS JW; HARRINGTON RA; LINCOFF AM; TOPOL EJ; CALIFF RM; BERDAN LG; WEATHERLY BD; WILCOX RG; ARMSTRONG PW; KITT MM; SIMOONS ML
      REGIONAL VARIATION IN OUTCOMES AS DETERMINED BY INVESTIGATORS AND CLINICAL EVENTS COMMITTEE IN AN INTERNATIONAL TRIAL OF EPTIFIBATIDE IN NON-ST SEGMENT ELEVATION ACUTE CORONARY SYNDROMES

      Journal of the American College of Cardiology
    66. ANDERSON RD; WHITE HD; OHMAN EM; WAGNER GS; KRUCOFF MW; ARMSTRONG PW; IPARRAGUIRRE HP; WEAVER WW; GIBLER WB; CALIFF RM
      RESOLUTION OF ST-SEGMENT ELEVATION 90 MINUTES AFTER THROMBOLYSIS FOR ACUTE MYOCARDIAL-INFARCTION PREDICTS OUTCOME - A GUSTO-III SUBSTUDY

      Journal of the American College of Cardiology
    67. Alexander, KP; Peterson, ED; Granger, CB; Casas, AC; Van de Werf, F; Armstrong, PW; Guerci, A; Topol, EJ; Califf, RM
      Potential impact of evidence-based medicine in acute coronary syndromes: Insights from GUSTO-IIb

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    68. Khadour, FH; O'Brien, DW; Fu, YL; Armstrong, PW; Schulz, R
      Endothelial nitric oxide synthase increases in left atria of dogs with pacing-induced heart failure

      AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
    69. BRAUNWALD E; MASERI A; ARMSTRONG PW; CALIFF RM; GIBLER WB; HAMM CW; SIMOONS ML; VANDEWERF F
      RATIONALE AND CLINICAL-EVIDENCE FOR THE USE OF GP IIB IIIA INHIBITORSIN ACUTE CORONARY SYNDROMES/

      European heart journal
    70. ARMSTRONG PW
      LOW-MOLECULAR-WEIGHT HEPARIN VERSUS UNFRACTIONATED HEPARIN FOR UNSTABLE CORONARY-DISEASE - REPLY

      The New England journal of medicine
    71. CHRISTENSON RH; DUH SH; NEWBY LK; OHMAN EM; CALIFF RM; GRANGER CB; PECK S; PIEPER KS; ARMSTRONG PW; KATUS HA; TOPOL EJ
      CARDIAC TROPONIN-T AND CARDIAC TROPONIN-I - RELATIVE VALUES IN SHORT-TERM RISK STRATIFICATION OF PATIENTS WITH ACUTE CORONARY SYNDROMES

      Clinical chemistry
    72. NEWBY LK; CHRISTENSON RH; OHMAN EM; ARMSTRONG PW; THOMPSON TD; LEE KL; HAMM CW; KATUS HA; CIANCIOLO C; GRANGER CB; TOPOL EJ; CALIFF RM
      VALUE OF SERIAL TROPONIN-T MEASURES FOR EARLY AND LATE RISK STRATIFICATION IN PATIENTS WITH ACUTE CORONARY SYNDROMES

      Circulation
    73. ARMSTRONG PW; FU YL; CHANG WC; TOPOL EJ; GRANGER CB; BETRIU A; VANDEWERF F; LEE KL; CALIFF RM
      ACUTE CORONARY SYNDROMES IN THE GUSTO-IIB TRIAL - PROGNOSTIC INSIGHTSAND IMPACT OF RECURRENT ISCHEMIA

      Circulation
    74. MASSIE BM; ARMSTRONG PW; CLELAND JGF; HOROWTIZ JJD; PACKER M; POOLEWILSON PA; RYDEN L
      EXCELLENT TOLERABILITY OF HIGH-DOSES OF LISINOPRIL IN THE ATLAS TRIAL

      Circulation
    75. KHADOUR FH; ARMSTRONG PW; OBRIEN DW; FU YL; SCHULZ R
      UP-REGULATION OF LEFT ATRIAL BUT NOT VENTRICULAR ENDOTHELIAL NITRIC-OXIDE SYNTHASE WITH PACING-INDUCED CONGESTIVE-HEART-FAILURE IN DOGS

      Circulation
    76. BATCHELOR WB; PETERSON ED; KNIGHT DJ; ARMSTRONG PW; GRANGER CB
      THE USE OF A CLINICAL PREDICTIVE MODEL FOR SEVERE CORONARY-ARTERY DISEASE IMPROVES THE EFFICIENCY OF CARDIAC-CATHETERIZATION IN BOTH THE USAND CANADA

      Circulation
    77. CLELAND JGF; MASSIE BM; PACKER M; ARMSTRONG PW; HOROWITZ JD; RYDEN L; POOLEWILSON PA
      HEALTH ECONOMIC-BENEFITS OF TREATING PATIENTS WITH HEART-FAILURE WITHHIGH-DOSE LISINOPRIL VERSUS LOW-DOSE - THE ATLAS STUDY

      Circulation
    78. URETSKY BF; ARMSTRONG PW; CLELAND JG; HOROWITZ JD; MASSIE BM; RYDEN L; PACKER M; POOLEWILSON PA
      ISCHEMIA AS A TRIGGER FOR SUDDEN-DEATH IN PATIENTS WITH CARDIOMYOPATHY AND HEART-FAILURE SECONDARY TO CORONARY-ARTERY DISEASE - RESULTS FROM THE ATLAS TRIAL

      Circulation
    79. HARRINGTON RA; GRAFFAGNINO G; ARMSTRONG PW; JOSEPH D; SIGMON KN; GRANETT JR; CHAN R; CALIFF RM; TOPOL EJ
      DOSE-FINDING AND TOLERABILITY OF A NEW ORAL PLATELET GLYCOPROTEIN IIBIIIA INHIBITOR, SB-214857, IN PATIENTS WITH CORONARY-ARTERY AND CEREBROVASCULAR-DISEASE - THE APLAUD RESULTS/

      Circulation
    80. CHOY JB; ULAN RA; CAMPBELL PM; PROSSER CI; ARMSTRONG PW; TYMCHAK WJ
      CLINICAL UTILITY AT CARDIAC TROPONIN-I AND 2ND-GENERATION CARDIAC TROPONIN-T IN HEMODIALYSIS-PATIENTS

      Circulation
    81. FU YL; ARMSTRONG PW; CHANG WC; OHMAN EM; GUPTA M; MORRIS A; ROTH SN; GRANGER CB; CALIFF RM; MARK DB
      IMPACT OF TEMPORAL TRENDS IN MANAGEMENT ON OUTCOMES OF ACUTE MYOCARDIAL-INFARCTION IN CANADA VERSUS US

      Circulation
    82. ARMSTRONG PW; FU YL; CHANG WC; MACKENZIE M; MARK DB; GRANGER CB; CALIFF RM
      CANADIAN-AMERICAN DIFFERENCES IN MANAGEMENT AND OUTCOME OF NON ST ELEVATION ACUTE CORONARY SYNDROMES - 6-MONTH FOLLOW-UP FROM THE GUSTO IIBSTUDY

      Circulation
    83. HUDSON MP; WHITE HD; ANDERSON RD; STEBBINS AL; GREENBAUM AB; WAGNER GS; ARMSTRONG PW; OHMAN EM
      BEDSIDE RISK STRATIFICATION USING BOTH TROPONIN-T AND ST-SEGMENT RESOLUTION IN ACUTE MYOCARDIAL-INFARCTION - A GUSTO-III SUBSTUDY

      Circulation
    84. STEINER B; HOFER U; WITTKE B; HARRINGTON RA; BHAPKAR MV; ARMSTRONG PW; MOLITERNO DJ
      PLASMA-LEVEL OF LAMIFIBAN AND PLATELET RECEPTOR OCCUPANCY BEST PREDICT CLINICAL OUTCOME IN PATIENTS WITH UNSTABLE ANGINA - RESULTS FROM PARAGON-A

      Circulation
    85. ARMSTRONG PW; FU YL; CHANG WC; GRANGER CB; BETRIU A; VANDEWERF F; LEE KL
      ACUTE CORONARY SYNDROMES - PROGNOSTIC INSIGHTS FROM GUSTO IIB

      Circulation
    86. GREENBAUM AB; HUDSON MP; MACAULAY CM; BERDAN LG; ARMSTRONG PW; KIELMAN NS; HARRINGTON RA
      TIMING OF EVENTS AFTER HOSPITALIZATION FOR ACUTE CORONARY SYNDROMES

      Circulation
    87. GOODMAN SG; LANGER A; ROSS AM; WILDERMANN NM; BARBAGELATA A; SGARBOSSA EB; WAGNER GS; GRANGER CB; CALIFF RM; TOPOL EJ; SIMOONS ML; ARMSTRONG PW
      NON-Q-WAVE VERSUS Q-WAVE MYOCARDIAL-INFARCTION AFTER THROMBOLYTIC THERAPY - ANGIOGRAPHIC AND PROGNOSTIC INSIGHTS FROM THE GLOBAL UTILIZATION OF STREPTOKINASE AND TISSUE-PLASMINOGEN ACTIVATOR FOR OCCLUDED CORONARY ARTERIES-I ANGIOGRAPHIC SUBSTUDY

      Circulation
    88. ARMSTRONG PW; WILLERSON JT
      CLINICAL CARDIOLOGY - NEW FRONTIERS

      Circulation
    89. KHADOUR FH; OBRIEN DW; FU Y; ARMSTRONG PW; SCHULZ R
      PACING-INDUCED HEART-FAILURE UP-REGULATES ENDOTHELIAL NITRIC-OXIDE SYNTHASE IN LEFT ATRIUM BUT NOT VENTRICLES

      British Journal of Pharmacology
    90. HOCHREIN J; SUN FC; PIEPER KS; LEE KL; GATES KB; ARMSTRONG PW; WEAVER WD; GOODMAN SG; TOPOL EJ; CALIFF RM; GRANGER CB; WAGNER GS
      HIGHER T-WAVE AMPLITUDE ASSOCIATED WITH BETTER PROGNOSIS IN PATIENTS RECEIVING THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION (A GUSTO-I SUBSTUDY)

      The American journal of cardiology
    91. URETSKY BF; PINA I; QUIGG RJ; BRILL JV; MACINERNEY EJ; MINTZER R; ARMSTRONG PW
      BEYOND DRUG-THERAPY - NONPHARMACOLOGIC CARE OF THE PATIENT WITH ADVANCED HEART-FAILURE

      The American heart journal
    92. BRAUNWALD E; MASERI A; ARMSTRONG PW; CALIFF RM; GIBLER WB; HAMM CW; SIMOONS ML; VANDEWERF F
      RATIONALE AND CLINICAL-EVIDENCE FOR THE USE OF GP IIB IIIA INHIBITORSIN ACUTE CORONARY SYNDROMES/

      The American heart journal
    93. ARMSTRONG PW; CAVERSON MM; ADAMS L; TAYLOR M; OLLEY PM
      EVALUATION OF THE HEART AND STROKE FOUNDATION OF CANADA RESEARCH SCHOLARSHIP PROGRAM - RESEARCH PRODUCTIVITY AND IMPACT

      Canadian journal of cardiology
    94. CHAN SY; MANCINI GBJ; FU YL; OBRIEN DW; ARMSTRONG PW
      NOVEL METHODOLOGY FOR ECHOCARDIOGRAPHIC QUANTIFICATION OF CARDIAC SHAPE

      Canadian journal of cardiology
    95. GILL S; MAJUMDAR S; BROWN NE; ARMSTRONG PW
      TICLOPIDINE-ASSOCIATED PANCYTOPENIA - IMPLICATIONS OF AN ACETYLSALICYLIC-ACID ALTERNATIVE

      Canadian journal of cardiology
    96. COX JL; NAYLOR CD; ARMSTRONG PW
      THROMBOLYTIC THERAPY - TIME TO TREATMENT - REPLY

      CMAJ. Canadian Medical Association journal
    97. COX JL; LEE E; LANGER A; ARMSTRONG PW; NAYLOR CD
      TIME TO TREATMENT WITH THROMBOLYTIC THERAPY - DETERMINANTS AND EFFECTON SHORT-TERM NONFATAL OUTCOMES OF ACUTE MYOCARDIAL-INFARCTION

      CMAJ. Canadian Medical Association journal
    98. HARRINGTON RA; MOLITERNO DJ; VANDEWERF F; KEECH A; KLEIMAN N; BHAPKAR M; RAMES A; PEEK M; TOPOL EJ; CALIFF RM; ARMSTRONG PW
      DELAYING AND PREVENTING ISCHEMIC EVENTS IN PATIENTS WITH ACUTE CORONARY SYNDROMES USING THE PLATELET GLYCOPROTEIN IIB IIIA INHIBITOR LAMIFIBAN/

      Journal of the American College of Cardiology
    99. HARRINGTON RA; NEWBY LK; MOLITERNO DJ; BHAPKAR M; ARMSTRONG PW; SIMES RJ; WHITE HD; VANDEWERF F; RAMES A; TOPOL EJ; CALIFF RM
      COMBINING IIB IIIA INHIBITION AND HEPARIN FOR ACUTE CORONARY SYNDROMES - EVIDENCE OF A GRADIENT FOR BLEEDING HAZARD FROM THE PARAGON RANDOMIZED FACTORIALLY DESIGNED TRIAL/

      Journal of the American College of Cardiology
    100. DZAVIK V; LOPASCHUK GD; JUGDUTT BI; STRYNADKA K; KHAN M; ARMSTRONG PW; OLLEY PM
      EFFECT OF ISCHEMIA AND REPERFUSION ON LYSOPLASMALOGEN ACCUMULATION INAN IN-VIVO CANINE MODEL

      Journal of the American College of Cardiology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/08/20 alle ore 14:19:14